Effects of using low-dosage Imipramine and normal-dosage Desmopressin on nocturnal enuresis in childre
Phase 3
- Conditions
- enuresis.Unspecified urinary incontinence
- Registration Number
- IRCT2016082129459N1
- Lead Sponsor
- Vice Chancellor for research of Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
primary nocturnal enuresis with single symptom; being of above 6 age; not having a kidney disorder; not having neurogenic bladder dysfunction; not being treated after using Desmopressin for one month.
Exclusion criteria: drug side effects; not completing the treatment period; allergy to Imipramine; suffering from heart disorder; suffering from heart arrhythmia.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bed wetting. Timepoint: Number of not bed wetting of the patient will be evaluated at baseline, 2 weeks later, 1 month later and then monthly until 6 months. Method of measurement: questionnaire.
- Secondary Outcome Measures
Name Time Method